The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 08, 2021
Filed:
Dec. 23, 2016
Applicant:
Julius-maximilians-universität Würzburg, Würzburg, DE;
Inventors:
Assignee:
JULIUS-MAXIMILIANS-UNIVERSITÄT WÜRZBURG, Würzburg, DE;
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/36 (2006.01); C07K 14/705 (2006.01); A61K 38/17 (2006.01); A61K 47/61 (2017.01); A61K 47/60 (2017.01); A61P 7/02 (2006.01); A61P 9/10 (2006.01); A61K 38/38 (2006.01); A61K 38/40 (2006.01); A61K 45/06 (2006.01); C07K 14/76 (2006.01); C07K 14/79 (2006.01);
U.S. Cl.
CPC ...
C07K 14/70596 (2013.01); A61K 38/177 (2013.01); A61K 38/38 (2013.01); A61K 38/40 (2013.01); A61K 45/06 (2013.01); A61K 47/60 (2017.08); A61K 47/61 (2017.08); A61P 7/02 (2018.01); A61P 9/10 (2018.01); C07K 14/76 (2013.01); C07K 14/79 (2013.01); C07K 2319/30 (2013.01); C07K 2319/31 (2013.01);
Abstract
A soluble polypeptide comprising a modified glycoprotein V (GPV) lacking a functional transmembrane domain for use in the treatment or prevention of a thrombotic disease in a subject, said treatment or prevention comprising administering to the subject an effective amount of said soluble polypeptide.